Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

NCT05013190

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Chao-Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hospital Beijing, Beijing Municipality, China
  • Henan Province People Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05130827

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

NCT05775094

Conditions
Blood Protein Disorders, Bone Diseases, Bone Diseases, Metabolic, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

NCT04184050

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

NCT05028348

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU Hôtel Dieu Nantes, France
  • CHU Hôpital Saint Antoine Paris, France
  • La Pitié Paris, France
  • Klinikum Chemnitz Chemnitz, Germany
View all 20 locations
View Trial Details
Active, Not Recruiting

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institute Goodyear, Arizona, United States
  • Local Institution - 0023 Anaheim, California, United States
  • Local Institution Anaheim, California, United States
View all 130 locations
View Trial Details

Related conditions